Viewing data from:

PREDNISONE

ANDA

PREDNISONE | A080356 | WATSON LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.3930

per ea

Lowest NADAC/Unit

$0.0366

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00591505221PREDNISONE 5 MG TAB DOSE PACK	$0.3930	EA	Generic	—	2026-06-17
00591505243PREDNISONE 5 MG TAB DOSE PACK	$0.3930	EA	Generic	—	2026-06-17
00591505201PREDNISONE 5 MG TABLET	$0.0366	EA	Generic	—	2026-06-17
00591505210PREDNISONE 5 MG TABLET	$0.0366	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain10 active DMFs5 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

EUROAPI FRANCEPREDNISONE

DMF 28741977

TIANJIN TIANYAO PHARMACEUTICALS CO LTDPREDNISONE USP

DMF 112891994

CURIA SPAIN SAUPREDNISONE ANHYDROUS USP

DMF 131731998

TIANJIN TIANYAO PHARMACEUTICALS CO LTDPREDNISONE ACETATE USP

DMF 139501999

HIKMA PHARMACEUTICALSPREDNISONE ANHYDROUS USP

DMF 160002002

HENAN LIHUA PHARMACEUTICAL CO LTDPREDNISONE

DMF 247492011

ZHEJIANG XIANJU PHARMACEUTICAL CO LTDPREDNISONE, NON-STERILE, BULK DRUG SUBSTANCE

DMF 301942015

HENAN LIHUA PHARMACEUTICAL CO LTDPREDNISONE ACETATE

DMF 316402017

SHANDONG XINHUA PHARMACEUTICAL CO LTDPREDNISONE ACETATE

DMF 344792020

SHANDONG XINHUA PHARMACEUTICAL CO LTDPREDNISONE

DMF 354612020

SYNTEX LABORATORIES INC SUB SYNTEX CORPInactivePREDNISONE(CRUDE AND CRYSTALLINE)

DMF 2411957

ROUSSEL CORPInactivePREDNISONE

DMF 2601957

PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INCInactivePREDNISONE MICRONIZED, STERILIZED AND ACETATE

DMF 14121969

DIOSYNTH BVInactivePREDNISONE MICRO

DMF 39561980

UPJOHN COInactivePREDNISONE ACETATE, MICRO & NON-MICRO

DMF 54921984

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.